Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last CNY17.71 CNY
Change Today -0.74 / -4.01%
Volume 226.6M
As of 3:05 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

kangmei pharmaceutical co-a (600518) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/11/15 - CNY25.89
52 Week Low
07/18/14 - CNY6.90
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for KANGMEI PHARMACEUTICAL CO-A (600518)

Related News

No related news articles were found.

kangmei pharmaceutical co-a (600518) Related Businessweek News

No Related Businessweek News Found

kangmei pharmaceutical co-a (600518) Details

Kangmei Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and medical devices in China. The company's principal products comprise Chinese medicines, including American ginseng, notoginseng powder, salvia powder, radix codonopsis pilosulae, maltiflower knotweed, angelica, lonicera flower, and others. It also offers chemical drugs, such as clarithromycin dispersible tablets, doxazosin mesylate tablets, propiverine hydrochloride tablets, paracetamol, pseudoephedrine hydrochloride tablets, and others. In addition, the company wholesales and retails in other medical materials comprising bird's nest, ganoderma, sea horse, isinglass, forest frog, and others. Kangmei Pharmaceutical Co., Ltd. was founded in 1997 and is based in Jieyang, China.

Founded in 1997

kangmei pharmaceutical co-a (600518) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kangmei pharmaceutical co-a (600518) Key Developments

Kangmei Pharmaceutical to Build Several Projects in Yunnan Province

Kangmei Pharmaceutical announced had reached a strategic cooperation agreement with the government of Pu'er city in Yunnan province. Under the agreement, the company will invest at least JPY 500 million in building a traditional Chinese medicinal materials plantation base and deep processing project, a traditional Chinese medicine and tea trade platform, a hospital investment project as well as an internet healthcare service platform.

Kangmei Pharmaceutical Co., Ltd. Announces Dividend Distribution on Preferred Shares for 2014, Payable on June 16, 2015

Kangmei Pharmaceutical Co., Ltd. implemented the scheme of dividend distribution on preferred shares in 2014 of RMB 0.58333 (taxes included), payable on June 16, 2015. Record date and Ex-dividend date is June 15, 2015.

Kangmei Pharmaceutical Co., Ltd. Announces Board Elections; Approves Cash Dividend for the Year 2014

Kangmei Pharmaceutical Co., Ltd. announced that at the Annual General Meeting held on 2 June 2015 approved the election of Ma Xingtian, Dongjin, Li Shi and Ma Hanyao as directors and Jiang Zhenping as independent director. The company also approved the cash dividend of CNY 3.2 per ten shares (tax included) for the year 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600518:CH CNY17.71 CNY -0.74

600518 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600518.
View Industry Companies

Industry Analysis


Industry Average

Valuation 600518 Industry Range
Price/Earnings 30.9x
Price/Sales 4.6x
Price/Book 5.3x
Price/Cash Flow 30.9x
TEV/Sales 3.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KANGMEI PHARMACEUTICAL CO-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at